Larimar Therapeutics, Inc. (NASDAQ:LRMR)
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
No revenue reported, so there is no margin to score.
- Revenue
- $0
- Net income
- -$172.6M
- Net margin
- —
Little or no net debt.
- Total debt
- $5.0M
- Cash
- $92.7M
- Debt / equity
- 0.04
Comfortably covers what is due within a year.
- Current assets
- $160.7M
- Current liabilities
- $34.2M
- Current ratio
- 4.70
Consumes cash and must keep raising it.
- Operating cash flow
- -$155.9M
- Free cash flow
- -$156.1M
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 103.9M
- Share growth (1y)
- 62.2%
- Cash runway
- 7 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
LRMR Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A Expense | 6.35 M | 6.09 M | 4.64 M | 4.67 M | 4.42 M | 4.64 M |
| R&D Expense | 28.00 M | 25.03 M | 59.37 M | 44.93 M | 23.37 M | 26.55 M |
| Operating Expenses | 34.35 M | 31.12 M | 64.02 M | 49.50 M | 27.79 M | 31.19 M |
| Operating Income | -34.35 M | -31.12 M | -64.02 M | -49.50 M | -27.79 M | -31.19 M |
| Pretax Income | -32.78 M | -29.61 M | -62.50 M | -47.71 M | -26.18 M | -29.28 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -32.78 M | -29.61 M | -62.50 M | -47.71 M | -26.18 M | -29.28 M |
| EPS (Basic) | -0.30 | -0.35 | -0.73 | -0.61 | -0.41 | -0.46 |
| EPS (Diluted) | -0.30 | -0.35 | -0.73 | -0.61 | -0.41 | -0.46 |
| Shares Outstanding | 103.88 M | 85.18 M | 85.18 M | 78.32 M | 64.03 M | 63.96 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.